Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing

PurposeThe clinical introduction of 68Ga-PSMA-11 (“HBED-CC”) ligand targeting the prostate-specific membrane antigen (PSMA) has been regarded as a significant step forward in the diagnosis of prostate cancer (PCa). In this study, we provide human dosimetry and data on optimal timing of PET imaging a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Afshar-Oromieh, Ali (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Giesel, Frederik L. (VerfasserIn) , Haberkorn, Uwe (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 3 June 2016
In: European journal of nuclear medicine and molecular imaging
Year: 2016, Jahrgang: 43, Heft: 9, Pages: 1611-1620
ISSN:1619-7089
DOI:10.1007/s00259-016-3419-0
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00259-016-3419-0
Verlag, Volltext: https://link.springer.com/article/10.1007/s00259-016-3419-0
Volltext
Verfasserangaben:Ali Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, Clemens Kratochwil, Frederik L. Giesel, Thomas A. Hope, Matthias Eder, Michael Eisenhut, Klaus Kopka, Uwe Haberkorn

MARC

LEADER 00000caa a2200000 c 4500
001 1565442482
003 DE-627
005 20230427142116.0
007 cr uuu---uuuuu
008 171116s2016 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00259-016-3419-0  |2 doi 
035 |a (DE-627)1565442482 
035 |a (DE-576)495442488 
035 |a (DE-599)BSZ495442488 
035 |a (OCoLC)1340982113 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Afshar-Oromieh, Ali  |d 1975-  |e VerfasserIn  |0 (DE-588)130260436  |0 (DE-627)496579711  |0 (DE-576)189580003  |4 aut 
245 1 0 |a Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing  |c Ali Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, Clemens Kratochwil, Frederik L. Giesel, Thomas A. Hope, Matthias Eder, Michael Eisenhut, Klaus Kopka, Uwe Haberkorn 
264 1 |c 3 June 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.11.2017 
500 |a Im Titel ist "68" in 68Ga-PSMA-11 hochgestellt 
520 |a PurposeThe clinical introduction of 68Ga-PSMA-11 (“HBED-CC”) ligand targeting the prostate-specific membrane antigen (PSMA) has been regarded as a significant step forward in the diagnosis of prostate cancer (PCa). In this study, we provide human dosimetry and data on optimal timing of PET imaging after injection.MethodsFour patients with recurrent PCa were referred for 68Ga-PSMA-11 PET/CT. Whole-body PET/CTlow-dose scans were conducted at 5 min, and 1, 2, 3, 4 and 5 h after injection of 152-198 MBq 68Ga-PSMA-11. Organs of moderate to high uptake were used as source organs; their total activity was determined at all measured time points. Time-activity curves were created for each source organ as well as for the remainder. The radiation exposure of a 68Ga-PSMA-11 PET was identified using the OLINDA-EXM software. In addition, tracer uptake was measured in 16 sites of metastases.ResultsThe highest tracer uptake was observed in the kidneys, liver, upper large intestine, and the urinary bladder. Mean organ doses were: kidneys 0.262 ± 0.098 mGy/MBq, liver 0.031 ± 0.004 mGy/MBq, upper large intestine 0.054 ± 0.041 mGy/MBq, urinary bladder 0.13 ± 0.059 mGy/MBq. The calculated mean effective dose was 0.023 ± 0.004 mSv/MBq (=0.085 ± 0.015 rem/mCi). Most tumor lesions (n = 16) were visible at 3 h p.i., while at all other time points many were not qualitatively present (10/16 visible at 1 h p.i.).ConclusionsThe mean effective dose of a 68Ga-PSMA-11 PET is 0.023 mSv/MBq. A 3-h delay after injection was optimal timing for 68Ga-PSMA-11 PET/CT in this patient cohort. 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
773 0 8 |i Enthalten in  |t European journal of nuclear medicine and molecular imaging  |d Heidelberg [u.a.] : Springer-Verl., 2002  |g 43(2016), 9, Seite 1611-1620  |h Online-Ressource  |w (DE-627)359787258  |w (DE-600)2098375-X  |w (DE-576)110279549  |x 1619-7089  |7 nnas  |a Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing 
773 1 8 |g volume:43  |g year:2016  |g number:9  |g pages:1611-1620  |g extent:10  |a Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing 
856 4 0 |u http://dx.doi.org/10.1007/s00259-016-3419-0  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00259-016-3419-0  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20171116 
993 |a Article 
994 |a 2016 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 10  |y j 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |e 910000PG129031240  |e 911400PG129031240  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 130260436  |a Afshar-Oromieh, Ali  |m 130260436:Afshar-Oromieh, Ali  |d 910000  |d 911400  |e 910000PA130260436  |e 911400PA130260436  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1565442482  |e 2987354517 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Ali Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, Clemens Kratochwil, Frederik L. Giesel, Thomas A. Hope, Matthias Eder, Michael Eisenhut, Klaus Kopka, Uwe Haberkorn"]},"id":{"eki":["1565442482"],"doi":["10.1007/s00259-016-3419-0"]},"origin":[{"dateIssuedDisp":"3 June 2016","dateIssuedKey":"2016"}],"relHost":[{"id":{"eki":["359787258"],"zdb":["2098375-X"],"issn":["1619-7089"]},"origin":[{"dateIssuedKey":"2002","publisher":"Springer-Verl.","dateIssuedDisp":"2002-","publisherPlace":"Heidelberg [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title":"European journal of nuclear medicine and molecular imaging"}],"part":{"issue":"9","pages":"1611-1620","year":"2016","extent":"10","text":"43(2016), 9, Seite 1611-1620","volume":"43"},"pubHistory":["29.2002 -"],"language":["eng"],"recId":"359787258","note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timingEuropean journal of nuclear medicine and molecular imaging"}],"physDesc":[{"extent":"10 S."}],"person":[{"given":"Ali","family":"Afshar-Oromieh","role":"aut","display":"Afshar-Oromieh, Ali","roleDisplay":"VerfasserIn"},{"given":"Clemens","family":"Kratochwil","role":"aut","roleDisplay":"VerfasserIn","display":"Kratochwil, Clemens"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Giesel, Frederik L.","given":"Frederik L.","family":"Giesel"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Haberkorn, Uwe","given":"Uwe","family":"Haberkorn"}],"title":[{"title":"Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing","title_sort":"Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing"}],"recId":"1565442482","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 16.11.2017","Im Titel ist \"68\" in 68Ga-PSMA-11 hochgestellt"]} 
SRT |a AFSHAROROMRADIATIOND3201